Skip to content

Does intravenous lidocaine associated with spinal anesthesia reduce post-operative pain after C-Section? The i-Lido-CA Trial

i-Lido-CA Trial: Intravenous Lidocaine for Cesarean Analgesia

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
PACTR
Registry ID
PACTR202310783988259
Enrollment
126
Registered
2023-10-31
Start date
2023-11-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery Anaesthesia

Interventions

G3 Standard Spinal Anesthesia with IV Placebo
G2 IV Lidocaine without spinal morphine
G1 IV lidocaine with spinal morphine

Sponsors

Syrine Aguir
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: • Age = 18 years; • Singleton evolving pregnancy; • Gestational age > 35 weeks; • Scheduled or semi-urgent cesarean section (decision-to-extraction interval >10 minutes); • Cesarean section under spinal anesthesia; • ASA (American Society of Anesthesiologists) Score 1 or 2; • Abiding by a 6-hour fasting period before the procedure; • Providing informed consent to participate in the protocol.

Exclusion criteria

Exclusion criteria: • Aged under 18 years; • General anesthesia for the cesarean section; • Emergency cesarean section; • Presence of placental insertion abnormalities; • Retroplacental hematoma; • Pregnancy-related pathologies (Preeclampsia, gestational diabetes...); • Non-cooperative, non-consenting, or having intellectual disability; • ASA (American Society of Anesthesiologists) Score = 3; • Contraindications for spinal anesthesia; • Conduction disorder; • Use of beta-blockers; • Opioid or psychotropic addiction; • Allergy to Lidocaine; • Porphyria; • Severe medical condition: renal, cardiac, or hepatic insufficiency; • A history of seizures or convulsive neurological disease. • Having had a conversion from spinal anesthesia to general anesthesia; • Failure of spinal anesthesia; • Experiencing a perioperative adverse event (anesthetic or surgical incident requiring resuscitation...); • Onset of signs of intoxication.

Design outcomes

Primary

MeasureTime frame
• The intensity of postoperative pain using the visual analog scale (VAS) measured at rest and during activity. • Perioperative hemodynamic variations: heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure (MAP).

Secondary

MeasureTime frame
• The time to the first postoperative analgesic request (in hours): between the administration of spinal anesthesia (T0) and the first analgesic request. • The need for additional postoperative analgesia. • Motor and sensory block duration in the postoperative period. • The occurrence of preoperative and postoperative nausea and vomiting. • The occurrence of preoperative and postoperative itching. • The time of bowel movement and the first postoperative ambulation. • Neonatal effects. • Maternal satisfaction. • The development of postoperative chronic pain.

Countries

Tunisia

Contacts

Public ContactMouna Gara

Attending at Anesthesia and Intensive Care Department at Fattouma Bourguiba B Maternity and Neonatology Center in Monastir.

gara_mouna@yahoo.fr+21698482338

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026